Characteristics of ST11 KPC-2-producing Carbapenem-resistant Hypervirulent Klebsiella Pneumoniae Causing Nosocomial Infection in a Chinese Hospital
Overview
Biotechnology
Pathology
Authors
Affiliations
Background: The purpose of our study is to analyze the microbiological and clinical characteristics of carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKP) that causes nosocomial infection.
Methods: We collected the carbapenem-resistant K. pneumoniae (CRKP) strains that caused nosocomial infection in a hospital in China and collected the relevant clinical data. We characterized these strains for their antimicrobial and virulence-associated phenotype and genotype and analyzed the clonal relatedness. We screened hypervirulent strains and compared them with non-hypervirulent strains.
Results: We retrospectively analyzed 62 CRKP strains that caused nosocomial infection in a tertiary hospital within 1 year, of which 41 (41/62, 66.1%) CRKP were considered as CR-hvKP. All CR-hvKP strains were multi-drug resistance (MDR) and the vast majority of isolates (39/41, 95.1%) were ST11 KPC-2-producing strains. Two hypermucoviscous isolates and 4 capsular types were found in 41 CR-hvKP. Twenty-nine isolates (29/41, 70.7%) showed hypervirulence in Galleria mellonella infection model. PFGE showed that ST11-KL47 CR-hvKP and ST11-KL64 CR-hvKP exhibited a high degree of clonality, while non-hypervirulent strains were not significant. CR-hvKP had higher positive rates of bla and bla and higher levofloxacin resistance (p < 0.001, p = 0.005 and p = 0.046, respectively) when compared to the non-hypervirulent strains. There was no significant difference between the two groups in terms of in-hospital mortality (7/41, 17.1% vs 5/21, 23.8%, p = 0.743).
Conclusion: Our research finds that ST11 KPC-2-producing CR-hvKP is the main type of CRKP that caused nosocomial infection, and clonal spread has occurred. We provide more information about CR-hvKP in health care.
Qala Nou M, Amirian Z, Dehghani F, Vejdan A, Rooin R, Dehghanmehr S BMC Pharmacol Toxicol. 2025; 26(1):25.
PMID: 39885589 PMC: 11783860. DOI: 10.1186/s40360-025-00857-8.
Jiang S, Ma Z, Cao H, Mo L, Jin J, Yu B Microb Genom. 2024; 10(9).
PMID: 39325028 PMC: 11541224. DOI: 10.1099/mgen.0.001299.
Virulence factors in carbapenem-resistant hypervirulent .
Mendes G, Santos M, Ramalho J, Duarte A, Caneiras C Front Microbiol. 2023; 14:1325077.
PMID: 38098668 PMC: 10720631. DOI: 10.3389/fmicb.2023.1325077.
Song S, Zhao S, Wang W, Jiang F, Sun J, Ma P Infect Drug Resist. 2023; 16:6017-6028.
PMID: 37705511 PMC: 10496924. DOI: 10.2147/IDR.S426901.
Xiao C, Li X, Huang L, Cao H, Han L, Ni Y Front Cell Infect Microbiol. 2023; 13:1118122.
PMID: 37143741 PMC: 10151768. DOI: 10.3389/fcimb.2023.1118122.